The efficacy of antivenom in prevention of cardiovascular depression and coagulopathy induced by Brown Snake species (Pseudonaja textilis, Pseudonaja affinis) was investigated in anaesthetised mechanically ventilated dogs. Venom and antivenom in variable amounts were incubated together at 3rCfor 30 minutes prior to intravenous injection. The dose of antivenom required to prevent severe cardiovascular depression and coagulopathy induced by Pseudonaja textilis venom was 25 times the current recommended dose for clinical use. A tenfold dose of anti venom was required to neutralise similar effects induced by Pseudonaja affinis venom. Large amounts of antivenom may be required in clinical use if coagulopathy or cardiovascular depression are present after envenomation by species of the Brown Snake genus.
The whole venom ofPseudonaja species has been recently demonstrated to cause severe cardiovascular depression in mechanically ventilated dogs. I This newly recognised effect of venom was associated with disturbances of coagulation 2 which included prolongation of prothrombin time and activated partial thromboplastin time, a reduction in serum fibrinogen and thrombocytopenia. Coagulopathy is a major feature of human Brown Snake envenomation; the blood is hypocoagulable, while laboratory tests usually reveal evidence of disseminated intravascular coagulation. Spontaneous haemorrhage may occur. 3·6 It is possible that the observed cardiovascular depression and coagulopath)'... are linked pathological processes. The efficacy of antivenom in preventing cardiovascular and haematological disturbances induced by whole venom of Pseudonaja textilis (Common or Eastern Brown Snake) and of Pseudonaja affinis (Dugite) is now reported. *B.Med.Sci., M.RRS., F.EA.RA-CS., Deputy Director. tM.D., D.Sc., ERA-CP., FRCPA-, Medical Consultant.
METHOD
The effect of Brown Snake antivenom (Commonwealth Serum Laboratories, Parkville, Victoria, Batch No. 05102 exp 3/91) was studied in eleven mongrel dogs. The anti venom was similar to that made available to medical and veterinary practitioners for the treatment of human and animal evenomation. The dogs were anaesthetised for the duration of the study. Approval for this study was granted by the Hospital Ethics Committee. Induction of anaesthesia was performed with intravenous injection of thiopentone 10-20 mg/kg and maintained with a mixture of halothane, oxygen and air delivered via endotracheal tube and a volume ventilator (CF Palmer, London). Minute ventilation was adjusted to maintain end-tidal carbon dioxide at 4.5-5.5%.
Frozen venom solution was thawed at 37"C. Antivenom was administered before infusion of Pseudonaja textilis venom in two dogs. Each received one ampoule (1000 Units), equivalent to 92 Ulkg and 65 Ulkg, over fifteen minutes followed by Pseudonaja textilis venom (1 0 ~g/kg) over two minutes. Nine dogs were subjected to intravenous infusion of an incubated mixture of whole venom (1 0 ~glkg) and antivenom at variable dosage over two minutes. Venom was incubated with antivenom in a water bath at 37"C for thirty minutes. Six of the dogs received a mixture of antivenom and Pseudonaja textilis venom while another three received a mixture of anti venom and Pseudonaja affinis venom. The doses of antivenom in the Pseudonaja textilis venom-anti venom mixtures were 0.5, 2.0, 5.0, 10.0, 25.0 and 50.0 V/kg. The doses of antivenom in the Pseudonaja affinis venom-antiven om mixtures were 2.0, 5.0 and 10.0 V/kg. Heart rate, blood pressure and central venous pressure were monitored continuously while cardiac output was measured by dye dilution before infusion of the mixtures and at 5 to 10 and at 30 to 40 minutes after infusion of the mixtures. Blood samples were withdrawn at these times for haematologica l tests. Details of cardiovascular monitoring and haematologica l tests are reported elsewhere. 1 ,2 
RESULTS

Pre-treatment with antivenom before venom 1. Cardiovascular
No substantial changes in heart rate, blood pressure, central venous pressure or cardiac output were observed in the two dogs during the infusion of 1000 Vnits of anti venom (equivalent to 92 V/kg and 65 V/kg). However, marked changes in all these haemodynami c parameters except central venous pressure were observed after the infusion of Pseudonaja textilis venom (1 0 ~glkg). Eight minutes after venom injection in one dog, the blood pressure had decreased from a mean of 100 mmHg to 27 mmHg while the cardiac output had decreased from 272 mllkglmin to 27 ml/kglmin and the heart rate had decreased from 158 to 116 beats/min. In the other dog, within five minutes after injection of venom, the blood pressure had decreased from a mean of 117 mmHg to 42 mmHg while the cardiac output had decreased from 219 mllkglmin to 35 ml/kglmin and the heart rate had decreased from 122 to 81 beats/min. No significant alteration in central venous pressure were noted in either dog. At 30 to 40 minutes after venom infusion, all haemodynami c indices had returned to levels similar to those before envenomation .
Haematologica l
Prior administration of antivenom failed to prevent the development of thrombocytop enia in the two dogs which received antivenom first followed by Pseudonaja textilis venom. In both dogs, the platelet count declined by 58%. Coagulation tests were performed for only one of the two dogs and these revealed a prolonged prothrombin time (41 seconds, normal 5 to 8 seconds) and activated partial thromboplasti n time (> 180 seconds, normal 11 to 17 seconds). Fibrin degradation products were slightly elevated at between 40 and 80 ~glml (normal < 1 0 ~glml).
Pseudonaja textilis venom incubated with antivenom 1. Cardiovascular
Severe disturbances of cardiovascular indices were observed in dogs receiving mixtures of venom and anti venom in which the dose of anti venom was 0.5,2.0 and 5. 0 V/kg. In these three dogs, marked decrements in blood pressure and cardiac output were observed 5 to 10 minutes after infusion of mixtures. The falls in blood pressure were from 101 to 58 mmHg (42.6%) from 118 to 35 mmHg (70.3%) and from 109 to 42 mmHg (61.5%). The falls in cardiac output were from 135 mllkglmin to 32 ml/kglmin (76%), 190 mllkglmin to 26 ml/kgl min (86%) and from 124 mllkglmin to 27 mllkgl min (78%). No significant changes were noted in the central venous pressures. The heart rate increased in the two receiving 0.5 V/kg and 5.0 V/kg but decreased in the dog receiving 2.0 V/kg of antivenom in the incubated mixtures. In the three .,.. .,; .,; .,; .,; .,;
-=~ however, blood pressure and cardiac output had returned to pre-infusion values. No marked alterations were observed in dogs infused with mixtures in which the antivenom dose was 5.0 and 10.0 V/kg. The absolute value of the cardiovascular indices in these dogs is presented in Table 3 .
Pseudonaja ajjinis venom incubated with
Haematological
Thrombocytopenia was observed in the three dogs infused with a mixture of Pseudonaja affinis venom and antivenom. The reductions in platelets 5 to 10 minutes after mixture administration were 81 %, 65% and 38%. Prolongation of the prothrombin and activated partial thromboplastin times and decrements in fibrinogen levels were observed in the dogs infused with venomantivenom mixtures containing 2.0 and 5.0 V/kg of antivenom. In contrast, these tests were normal in the dog infused with the mixture containing 10 V/kg of antivenom. Fibrin degradation products or cross-linked fibrin degradation products were not raised in any of these three dogs after receiving mixtures of venom and antivenom. The absolute values of the platelet counts and coagulation tests for each dog infused with venom-antivenom mixture is presented in Table 4 .
DISCUSSION
The dose of antivenom recommended for current clinical use has been determined by guinea pig survival experiments. One unit of antivenom neutralises 10 )lg of dried snake venom. 3 Commercially available ampoules of antivenom contain 1000 units of antivenom which thus should neutralise 10 mg of venom. Since the average venom yield ofPseudonaja textilis at first bite is 4.7 mg,? one ampoule ought to be a sufficient neutralisation dose. Indeed, clinical case reports have verified that coagulopathy induced by Pseudonaja spp is corrected by Common Brown Snake (Pseudonaja textilis) anti venom. 3, 4 However, several or many ampoules of antivenom may be required 3 ,5 which casts doubt upon the neutralisation dose of antivenom. As the Anaesthesia and Intensive Care, Vol. 19, No. 4. November, 1991 cardiovascular effects of Pseudonaja textilis and of Pseudonaja affinis appear to be sensitive indicators of envenomation, it is appropriate to determine the dose of antivenom required to neutralise those cardiovascular effects and to perform in vivo coagulopathy neutralisation tests.
The cardiovascular effects of Pseudonaja textilis venom were neutralised when large quantities of anti venom were incubated with venom prior to injection in dogs. When 25 to 50 times the neutralisation dose of antivenom was incubated with venom, the cardiovascular effects of venom were insignificant. However, 0.5 to 5.0 times the dose of antivenom did not prevent severe reduction in blood pressure and cardiac output while ten times the dose minimized the cardiovascular depression. The cardiovascular effects of Pseudonaja affinis venom were not prevented by prior incubation with antivenom in a dose twice that expected to neutralise the effects of the venom. The effects of Pseudonaja affinis venom were, however, ameliorated by five times the neutralisation dose of antivenom and prevented by ten times the neutralisation dose of anti venom. This study also revealed that ID to 25 times the recommended dose of antivenom in a venomantivenom mixture was necessary to prevent coaguiopathy.
The mechanism of venom-induced hypotension has been postulated as depression of myocardial con tractility . 1 The observations here of hypotension and low cardiac output after administration of mixtures with high venom and low antivenom are consistent with this hypothesis. However, only small increments in central venous pressures were observed in the small number of animals. The use of echocardiographic wall motion studies and measurement of pulmonary artery pressure may elucidate the mechanism of venominduced cardiovascular depression.
It has been suggested that the venom of Pseudonaja affinis is more potent than that of Pseudonaja textilis in the production of coagulopathy in the monkey.s This suggestion is not supported by observations made here. On the contrary, the venom ofPseudonaja textilis appears more potent than that of Pseudonaja affinis in the production of both coagulopathy and cardiovascular depression.
In the clinical treatment of envenomation by all species of Brown Snake,. it may be prudent to administer more than the recommended dose of antivenom if either cardiovascular or coagulopathy depression is a feature of the envenomation syndrome. Consumed clotting factors should be replaced and the coagulation status monitored frequently.
